rKLO8, a Novel Leishmania donovani - Derived Recombinant Immunodominant Protein for Sensitive Detection of Visceral Leishmaniasis in Sudan

PLoS Neglected Tropical Diseases

Volumn 7, Issue 7, 2013, Pages

  Abass, Elfadil ^a,b   Bollig, Nadine ^a   Reinhard, Katharina ^a   Camara, Bärbel ^a   Mansour, Durria ^b   Visekruna, Alexander ^a   Lohoff, Michael ^a   Steinhoff, Ulrich ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b AHFAD UNIVERSITY FOR WOMEN   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

IMIDAZOLE; IMMUNOGLOBULIN G ANTIBODY; PROTEIN RK39; PROTOZOAL PROTEIN; RECOMBINANT PROTEIN; RK39 PROTEIN; RKLO8 PROTEIN; UNCLASSIFIED DRUG;

AGGLUTINATION TEST; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; LEISHMANIA DONOVANI; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SENSITIVITY AND SPECIFICITY; SUDAN; VISCERAL LEISHMANIASIS; WESTERN BLOTTING;

EID: 84880835409     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002322     Document Type: Article

References (48)

1. Lainson R, Shaw JJ (1987) Evolution, classification and geographical distribution. In: Peters W, Killick-Kendrick R, editors. The leishmaniases in biology and medicine. London: Academic Press. 1-120.
2. Jamjoom MB, Ashford RW, Bates PA, Chance ML, Kemp SJ, et al. (2004) Leishmania donovani is the only cause of visceral leishmaniasis in East Africa; previous descriptions of L. infantum and "L. archibaldi" from this region are a consequence of convergent evolution in the isoenzyme data. Parasitology 129: 399-409.
3. Mauricio IL, Stothard JR, Miles MA, (2000) The strange case of Leishmania chagasi. Parasitol Today 16: 188-189.
4. Lukes J, Mauricio IL, Schonian G, Dujardin JC, Soteriadou K, et al. (2007) Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proc Natl Acad Sci USA 104: 9375-9380.
5. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, et al. (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7: e35671.
6. Zijlstra EE, el-Hassan AM, (2001) Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 95 Suppl 1: S27-58.
7. Ritmeijer K, Melaku Y, Mueller M, Kipngetich S, O'keeffe C, et al. (2006) Evaluation of a new recombinant K39 rapid diagnostic test for Sudanese visceral leishmaniasis. Am J Trop Med Hyg 74: 76-80.
8. Croft SL, Yardley V, (2002) Chemotherapy of leishmaniasis. Curr Pharm Des 8: 319-342.
9. Croft SL, Coombs GH, (2003) Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 19: 502-508.
10. Burns JM Jr, Shreffler WG, Benson DR, Ghalib HW, Badaro R, et al. (1993) Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A 90: 775-9.
11. Sivakumar R, Sharma P, Chang KP, Singh S, (2006) Cloning, expression and purification of a novel recombinant antigen from Leishmania donovani. Protein Expr Purif 46: 156-165.
12. Singh S, Sacks AG, Chang KP, Reed SG, (1995) Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis. J Parasitol 81: 1000-1003.
13. Badaró R, Benson D, Eulálio MC, Freire M, Cunha S, et al. (1996) rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis 173: 758-61.
14. Ozensoy S, Ozbel Y, Turgay N, Alkan MZ, Gul K, et al. (1998) Serodiagnosis and epidemiology of visceral leishmaniasis in Turkey. Am J Trop Med Hyg 59: 363-369.
15. Medrano FJ, Canavate C, Leal M, Rey C, Lissen E, et al. (1998) The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1. Am J Trop Med Hyg 59: 155-162.
16. Houghton RL, Petrescu M, Benson DR, Skeiky YA, Scalone A, et al. (1998) A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy. J Infect Dis 177: 1339-1344.
17. Maalej IA, Chenik M, Louzir H, Ben Salah A, Bahloul C, et al. (2003) Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis. Am J Trop Med Hyg 68: 312-320.
18. Zijlstra EE, Nur Y, Desjeux P, Khalil EA, El-Hassan AM, et al. (2001) Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. Trop Med Int Health 6: 108-113.
19. Veeken H, Ritmeijer K, Seaman J, Davidson R, (2003) Comparison of an rK39 dipstick rapid test with direct agglutination test and splenic aspiration for the diagnosis of kala-azar in Sudan. Trop Med Int Health 8: 164-167.
20. Cunningham J, Hasker E, Das P, El Safi S, Goto H, et al. (2012) Comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis 55: 1312-1319.
21. Sivakumar R, Dey A, Sharma P, Singh S, (2008) Expression and characterization of a recombinant kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a commercially available antigen from a newly isolated (KE16) strain of L. donovani. Infect Genet Evol 8: 313-22.
22. Harith AE, Kolk AH, Kager PA, Leeuwenburg J, Muigai R, et al. (1986) A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis. Trans R Soc Trop Med Hyg 80: 583-536.
23. Mengistu G, Kiessling R, Akuffo H, (1990) The value of a direct agglutination test in the diagnosis of cutaneous and visceral leishmaniasis in Ethiopia. Trans R Soc Trop Med Hyg 84: 359-62.
24. Shiddo SA, Akuffo HO, Mohamed AA, Huldt G, Nilsson LA, et al. (1995) Visceral leishmaniasis in Somalia: prevalence of leishmanin-positive and seropositive inhabitants in an endemic area. Trans R Soc Trop Med Hyg 89: 21-4.
25. Boelaert M, El Safi S, Mousa H, Githure J, Mbati P, et al. (1999) Multi-centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis. Trop Med Int Health 4: 31-37.
26. Abass EM, Mansour D, Harith AE, (2007) Demonstration of agglutinating anti-Leishmania antibodies in lymph node aspirate for confirmation of kala-azar serodiagnosis. J Med Microbiol 56: 1256-1258.
27. Srivastava P, Dayama A, Mehrotra S, Sundar S, (2011) Diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 105: 1-6.
28. Boelaert M, Lynen L, Desjeux P, Van der Stuyft P, (1999) Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis. Bull World Health Organ 77: 667-674.
29. Harith AE, Mutasim M, Mansour D, Abass E, Arvidson H, (2003) Use of glycerol as an alternative to freeze drying for long term preservation of antigen for direct agglutination. Trop Med Int Health 11: 1025-1029.
30. Abass EM, Mansour D, El Mutasim M, Hussein M, El Harith A, (2006) Beta-mercaptoethanol modified ELISA for diagnosis of visceral leishmaniasis. J Med Microbiol 55: 1193-96.
31. Mutasim M, Mansour D, Abass EM, Hassan WM, El Harith A, (2006) Evaluation of a glycerol preserved antigen in the direct agglutination test for diagnosis of visceral leishmaniasis at rural level in eastern Sudan. J Med Microbiol 55: 1343-47.
32. Benson G, (1999) Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res 27: 573-580.
33. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
34. Harith AE, Kolk AH, Leeuwenburg J, Muigai R, Huigen E, Jelsma T, Kager PA, (1988) Improvement of a direct agglutination test for field studies of visceral leishmaniasis. J Clin Microbiol 26: 1321-1325.
35. Meredith SE, Kroon NC, Sondorp E, Seaman J, Goris MG, et al. (1995) Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis. J Clin Microbiol 33: 1742-1745.
36. Newcombe RG, (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17: 857-72.
37. Pattabhi S, Whittle J, Mohamath R, El-Safi S, Moulton GG, et al. (2010) Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis. PLoS Negl Trop Dis 4: e822.
38. Mabey D, Peeling RW, Ustianowski A, Perkins MD, (2004) Diagnostics for the developing world. Nat Rev Microbiol 2: 231-240.
39. Dey A, Sharma U, Singh S, (2007) First case of indigenous visceral leishmaniasis from central India. Am J Trop Med Hyg 77: 95-8.
40. Bhattacharyya T, Boelaert M, Miles MA, (2013) Comparison of Visceral Leishmaniasis Diagnostic Antigens in African and Asian Leishmania donovani Reveals Extensive Diversity and Region-specific Polymorphisms. PLoS Negl Trop Dis 7 (2):: e2057.
41. Garcez LM, Silveira FT, Harith AE, Lainson R, Shaw JJ, (1997) Experimental cutaneous leishmaniasis. IV. The humoral response of Cebus apella (Primates: Cebidae) to infections of Leishmania (Leishmania) amazonensis, L. (Viannia) lainsoni and L. (V.) braziliensis using the direct agglutination test. Acta Trop 68: 65-76.
42. Ribeiro FC, Schubach Ade O, Mouta-Confort E, Pacheco TM, Madeira Mde F, et al. (2011) Use of ELISA employing homologous and heterologous antigens for the detection of IgG and subclasses (IgG1 and IgG2) in the diagnosis of canine visceral leishmaniasis. Rev Inst Med Trop Sao Paulo 53: 283-9.
43. Forgber M, Basu R, Roychoudhury K, Theinert S, Roy S, et al. (2006) Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology. PLoS One 1: e40.
44. Takagi H, Islam MZ, Itoh M, Islam A, Ekram ARMS, et al. (2007) Production of recombinant kinesin-related protein of Leishmania donovani and its application in the serodiagnosis of visceral leishmaniasis. Am J Trop Med Hyg 76: 902-5.
45. Piarroux R, Gambarelli F, Dumon H, Fontes M, Dunan S, et al. (1994) Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral Leishmaniasis in immunocompromised patients. J Clin Microbiol 32: 746-749.
46. de Beer P, Harith AE, Deng LL, Semiao-Santos SJ, Chantal B, van Grootheest M, (1991) A killing disease epidemic among displaced Sudanese population identified as visceral leishmaniasis. Am J Trop Med Hyg 44: 283-9.
47. van den Bogaart E, Berkhout MM, Adams ER, Mens PF, Sentongo E, et al. (2012) Prevalence, features and risk factors for malaria co-infections amongst visceral leishmaniasis patients from Amudat Hospital, Uganda. PLoS Negl Trop Dis 6: e1617.
48. Romero HD, Silva LA, Silva-Vergara ML, Rodrigues V, Costa RT, et al. (2009) Comparative study of serologic tests for the diagnosis of asymptomatic visceral leishmaniasis in an endemic area. Am J Trop Med Hyg 81: 27-33.